Molecular Responses at 3 and 6 Months Predict Outcomes in Patients With Chronic Myeloid Leukemia in Chronic Phase Treated With Front-line lmatinib: Taiwan CML Study Group

Ming-Chung Kuo; Tsai-Yun Chen; Ming-Chung Wang; Tseng-Hsi Lin; Li-Yaun Bai; Yii-Jenq Lan; Chih-cheng Chen; Pei-Ching Hsiao; Wen-Li Hwang; Su-Peng Yeh; Ching-Yuan Kuo; Lee-Yung Shih

Molecular Responses at 3 and 6 Months Predict Outcomes in Patients With Chronic Myeloid Leukemia in Chronic Phase Treated With Front-line lmatinib: Taiwan CML Study Group

Ming-Chung Kuo
, Tsai-Yun Chen
, Ming-Chung Wang
, Tseng-Hsi Lin
, Li-Yaun Bai
, Yii-Jenq Lan
, Chih-cheng Chen
, Pei-Ching Hsiao
, Wen-Li Hwang
, Su-Peng Yeh
, Ching-Yuan Kuo
, Lee-Yung Shih

School of Medicine

Research output: Contribution to journal › Journal Article › peer-review

Original language	American English
Journal	CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Volume	14
State	Published - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

Kuo, M.-C., Chen, T.-Y., Wang, M.-C., Lin, T.-H., Bai, L.-Y., Lan, Y.-J., Chen, C., Hsiao, P.-C., Hwang, W.-L., Yeh, S.-P., Kuo, C.-Y., & Shih, L.-Y. (2014). Molecular Responses at 3 and 6 Months Predict Outcomes in Patients With Chronic Myeloid Leukemia in Chronic Phase Treated With Front-line lmatinib: Taiwan CML Study Group. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 14.

@article{82d25ab1cf4b47328e12753f5dc87765,

title = "Molecular Responses at 3 and 6 Months Predict Outcomes in Patients With Chronic Myeloid Leukemia in Chronic Phase Treated With Front-line lmatinib: Taiwan CML Study Group",

author = "Ming-Chung Kuo and Tsai-Yun Chen and Ming-Chung Wang and Tseng-Hsi Lin and Li-Yaun Bai and Yii-Jenq Lan and Chih-cheng Chen and Pei-Ching Hsiao and Wen-Li Hwang and Su-Peng Yeh and Ching-Yuan Kuo and Lee-Yung Shih",

year = "2014",

language = "American English",

volume = "14",

journal = "CLINICAL LYMPHOMA MYELOMA \& LEUKEMIA",

issn = "2152-2650",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Molecular Responses at 3 and 6 Months Predict Outcomes in Patients With Chronic Myeloid Leukemia in Chronic Phase Treated With Front-line lmatinib: Taiwan CML Study Group

AU - Kuo, Ming-Chung

AU - Chen, Tsai-Yun

AU - Wang, Ming-Chung

AU - Lin, Tseng-Hsi

AU - Bai, Li-Yaun

AU - Lan, Yii-Jenq

AU - Chen, Chih-cheng

AU - Hsiao, Pei-Ching

AU - Hwang, Wen-Li

AU - Yeh, Su-Peng

AU - Kuo, Ching-Yuan

AU - Shih, Lee-Yung

PY - 2014

Y1 - 2014

M3 - Journal Article

SN - 2152-2650

VL - 14

JO - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

JF - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

ER -